期刊文献+

米非司酮基因诱导调控系统 被引量:2

Advancement in Mifepristone -inducible Regulatory System
下载PDF
导出
摘要 在基因表达和基因治疗研究中,需要目的基因在特定的时间以适当的水平实现其表达,目的基因过度表达或不适当的表达将影响实验结果,在疾病治疗中甚至会产生致命的副作用,实现对目的基因的表达时间和表达水平的精确调控是一个非常关键的问题。目前生物学家们已构建了多种新型的基因表达调控系统,其中米非司酮诱导调控系统具有诱导效率高,背景表达低,安全性高等诸多优点,是基因调控研究中的重要进展,也是目前最有应用前景的调控系统之一。就其结构设计和应用研究方面的进展作一简要综述。 It is important that the the expression level and timing time of a target gene is regulated and controlled in the study of gene therapy and gene function. Constitutive or inappropriate expression of the genes with traditional expression systems may interfere with the effects of the gene therapy, even may lead to lethal side effects. Inducible expression systems can be used to regulate the expression level of genes of interest in appropriate time according to the aim of the experiments. Up to date, several inducible expression systems have been established and become the potent tools for gene therapy and studying the function of genes of interest. One of the most promising regulatory systems is the mifepristone-regulated system, which has much lower basal transcriptional activity and high inducibility. Recent developments in system design and application was reviewed.
作者 陈坚 薛绪潮
出处 《中国生物工程杂志》 CAS CSCD 北大核心 2008年第1期87-90,共4页 China Biotechnology
基金 国家自然科学基金资助项目(30571830)
关键词 米非司酮 调控系统 Mifepristone Regulatory system
  • 相关文献

参考文献1

二级参考文献46

  • 1Abruzzese RV, Godin D, Mehta V, et al. Ligand-dependent regulation of vascular endothelial growth factor and erythropoietin expression by a plasmid-based autoinducible Gene Switch system. Mol Ther 2000: 2:276-87.
  • 2Prieto J, Qian C, Sangro B, Melero Ⅰ, Mazzolini G. Biological therapy of liver tumors. Surg Clin North Am 2004; 84:643-57.
  • 3Trinchieri G. Interleukin- 12: a cytokine at the interface of inflammation and immunity. Adv Immunol 1998; 70:83-243.
  • 4Caruso M, Pham-Nguyen K, Kwong YL, et al, Adenovirus-mediated interleukin-12 gene therapy for metastatic colon carcinoma.Proc Natl Acad Sci U S A 1996: 93:11302-6.
  • 5Mazzolini G, Qian C, Xie X, et al. Tumor regression and long-term protection for colon cancer after intratumoral injection of adenovirus expressing IL-12. Cancer Gene Ther 1999; 5:514-22.
  • 6Barajas M, Mazzolini G, Genove G, et al, Gene Therapy of Orthotopic Hepatocellular Carcinoma in Rats Using Adenovirus Coding for interleukin-12 (IL-12). Hepatology 2001; 33:52-61.
  • 7Liu Y, Ehtesham M, Samoto K, et al. In situ adenoviral interleukin 12 gene transfer confers potent and long-lasting cytotoxic immunity in glioma. Cancer Gene Ther 2002: 9:9-15.
  • 8Nasu Y, Bangma CH, Hull GW, et al. Adenovirus-mediated interleukin-12 gene therapy for prostate cancer: suppression of orthotopic tumor growth and pre-established lung metastases in an orthotopic model Gene Ther 1999: 6:338-49.
  • 9Zhang R, DeGroot LJ. Gene therapy of a rat follicular thyroid carcinoma model with adenoviral vectors transducing murine interleukin- 12. Endocrinology 2003; 144:1393-8.
  • 10Wang L, Hemandez-Aicoceba R, Shankar V, et al. Prolonged and inducible transgene expression in the liver using gutless adenovirus: A potential therapy tbr liver cancer. Gastroenterology 2004; 126: 278-89.

共引文献12

同被引文献3

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部